Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PBLSParabilis Medicines, Inc.

Nasdaq · CIK 0001657677
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts161

Identity from submissions API

NameParabilis Medicines, Inc.
CIK0001657677
TickersPBLS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN474505725
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-945-9510
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • FOG PHARMACEUTICALS, INC. (2015-11-13T05:00:00.000Z → 2022-12-02T05:00:00.000Z)
Business address
30 ACORN PARK DRIVE
6TH FLOOR
CAMBRIDGE
MA
02140
MA
Mailing address
30 ACORN PARK DRIVE
6TH FLOOR
CAMBRIDGE
MA
02140
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

65 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q 10-Q 0001193125-26-458388 001-43331 261547042 34 13299238 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-456892 001-43331 261543111 34 633626 1 1
2026-11-05 8-K 8-K 1.01 0001193125-26-449869 001-43331 261527537 34 166362 1 1
2026-09-15 8-K 8-K 7.01 0001193125-26-391952 001-43331 261380977 34 159976 1 1
2026-09-02 8-K 8-K 5.02 0001193125-26-380171 001-43331 261354721 34 162453 1 1
2026-08-25 4 4 0001193125-26-365484 5484
2026-08-25 3 3 0001193125-26-365459 19551
2026-08-25 8-K 8-K 5.02,7.01,9.01 0001193125-26-365132 001-43331 261315808 34 310393 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352189 005-95761 261281153 34 34144
2026-08-13 10-Q 10-Q 0001193125-26-349168 001-43331 261273318 34 12038891 1 1
2026-08-13 8-K 8-K 2.02,7.01,9.01 0001193125-26-347869 001-43331 261270025 34 18884016 1 1
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002123 005-95761 261247193 34 11684
2026-07-22 4 xslF345X06/form4-07222026_080742.xml 0001231919-26-000779 25016
2026-06-29 4 xslF345X06/ownership.xml 0001213900-26-072928 28040
2026-06-29 3 xslF345X06/ownership.xml 0001213900-26-072925 15123
2026-06-18 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000178 005-95761 261102607 34 27623
2026-06-16 4 4 0001193125-26-273013 9612
2026-06-15 4 xslF345X06/form4-06152026_100639.xml 0001231919-26-000638 27432
2026-06-15 4 4 0001193125-26-271344 14669
2026-06-15 4 4 0001193125-26-271324 5477
2026-06-15 4 4 0001193125-26-271300 7129
2026-06-11 4 xslF345X06/e665575_4-pbls.xml 0001193805-26-000798 55923
2026-06-11 4 xslF345X06/form4-06112026_100601.xml 0001231919-26-000623 14399
2026-06-11 4 4 0001193125-26-267806 5567
2026-06-11 4 4 0001193125-26-267802 5560
2026-06-11 4 4 0001193125-26-267797 5575
2026-06-11 4 4 0001193125-26-267769 5574
2026-06-11 4 4 0001193125-26-267766 5573
2026-06-11 4 4 0001193125-26-267747 5522
2026-06-11 4 4 0001193125-26-267733 5482
2026-06-11 8-K 8-K 1.01,3.02,5.03,9.01 0001193125-26-267550 001-43331 261083157 34 639186 1 1
2026-06-10 S-8 S-8 0001193125-26-266037 333-296683 261080563 33 351907 1 1
2026-06-10 424B4 424B4 0001193125-26-265983 333-296032 261080385 33 23163695
2026-06-10 FWP FWP 0001193125-26-264521 333-296032 261077731 34 22130
2026-06-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001929 333-296032 261077892 33 1862
2026-06-09 3 xslF345X06/form3-06102026_010620.xml 0001231919-26-000614 17182
2026-06-09 3 3 0001193125-26-264599 22205
2026-06-09 3 3 0001193125-26-264596 16876
2026-06-09 3 3 0001193125-26-264592 20696
2026-06-09 3 3 0001193125-26-264589 16780
2026-06-09 3 xslF345X06/e665567_3-pbls.xml 0001193805-26-000786 32900
2026-06-09 3 3 0001193125-26-264583 19650
2026-06-09 3 3 0001193125-26-264578 19343
2026-06-09 3 3 0001193125-26-264575 18383
2026-06-09 3 3 0001193125-26-264573 24673
2026-06-09 3 3 0001193125-26-264567 19647
2026-06-09 3 3 0001193125-26-264563 16539
2026-06-09 3 3 0001193125-26-264556 18219
2026-06-09 3 3 0001193125-26-264550 20697
2026-06-09 3 3 0001193125-26-264547 21102
2026-06-09 S-1MEF S-1MEF 0001193125-26-264426 333-296655 261077513 33 281303
2026-06-09 CERT 8A_Cert_PBLS_0001657677.pdf 0001354457-26-000549 001-43331 261075379 34 180985
2026-06-09 S-1/A S-1/A 0001193125-26-262880 333-296032 261074508 33 23582034
2026-06-05 8-A12B 8-A12B 0001193125-26-259552 001-43331 261069112 34 39987
2026-06-04 S-1/A S-1/A 0001193125-26-256398 333-296032 261063132 33 25560953
2026-05-27 S-1/A S-1/A 0001193125-26-242067 333-296032 261027222 33 12880501
2026-05-19 S-1 S-1 0001193125-26-230994 333-296032 26999901 33 26409346 1 1
2026-04-02 DRS filename1.htm 0001193125-26-140488 377-09210 26835286 33 13671006
2022-12-02 D xslFormDX01/primary_doc.xml 06b 0001657677-22-000001 021-466472 221442695 33 11957
2021-01-05 D xslFormDX01/primary_doc.xml 06b 0001657677-21-000002 021-385216 21504241 33 11076
2018-05-16 D/A xslFormDX01/primary_doc.xml 06b 0001657677-18-000003 021-305650 18839620 33 9433
2018-02-14 D xslFormDX01/primary_doc.xml 06b 0001657677-18-000002 021-305650 18611980 33 9340
2017-08-22 D/A xslFormDX01/primary_doc.xml 06b 0001657677-17-000001 021-264481 171045625 33 8688
2016-06-07 D xslFormDX01/primary_doc.xml 06b 0001657677-16-000004 021-264481 161700417 33 7586
2015-11-13 D xslFormDX01/primary_doc.xml 06b 0001657677-15-000002 021-251210 151228433 33 6085

Latest XBRL company facts

One latest value per concept from companyfacts (161 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
ffd NetFeeAmt NetFeeAmt USD 25,145.71 2026-06-09 S-1/A 2026-06-09 0001193125-26-262880
ffd TtlFeeAmt TtlFeeAmt USD 100,582.83 2026-06-09 S-1/A 2026-06-09 0001193125-26-262880
ffd TtlOfferingAmt TtlOfferingAmt USD 728.33M 2026-06-09 S-1/A 2026-06-09 0001193125-26-262880
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-06-09 S-1/A 2026-06-09 0001193125-26-262880
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 75,437.12 2026-06-09 S-1/A 2026-06-09 0001193125-26-262880
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 20.21M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 443,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 8.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 24.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 14.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.69B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap Assets Assets USD 1.13B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap AssetsCurrent Assets, Current USD 879.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 277,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349168
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 521.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 524.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 493.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 27.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 600.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 122.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 122.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap CommonStockValue Common Stock, Value, Issued USD 12,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -144.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 814.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 55.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 2.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DebtCurrent Debt, Current USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 15.00M 2021-09-21 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 543.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DebtSecuritiesHeldToMaturityTransferToAvailableForSaleAllowanceForCreditLossExpense Debt Securities, Held-to-Maturity, Transfer to Available-for-Sale, Allowance for Credit Loss, Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 5.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 13.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 27.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap DividendIncomeOperating Dividend Income, Operating USD 7.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 27.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 684,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 951,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 473,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 609,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 443,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 40.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -5.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 7.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 419,506 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 626,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap InterestIncomeOther Interest Income, Other USD 16.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 520,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 5.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap Liabilities Liabilities USD 126.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.13B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LiabilitiesCurrent Liabilities, Current USD 68.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LineOfCreditFacilityCommitmentFeePercentage Line of Credit Facility, Commitment Fee Percentage pure 0.5 2024-11-01 2024-11-22 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 60.00M 2024-11-22 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 750,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 700,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349168
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 936,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap MarketableSecurities Marketable Securities USD 551.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 350.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 201.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 1 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.14B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -552.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -93.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -142.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -182.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 10.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OperatingExpenses Operating Expenses USD 155.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -153.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 7.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 30.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 34.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 4.60M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OtherAssets Other Assets USD 4.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap OtherLiabilities Other Liabilities USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PaymentsForCommissions Payments for Commissions USD 57.60M 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 5.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 11.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 680,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 560.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1 PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1 USD -7.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 6.43 2024-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 718.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 712.90M 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 811.80M 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 15.00M 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 83.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.60M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 9.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -142.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 24.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 122.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap RestrictedCash Restricted Cash USD 2.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 524.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -683.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap Revenues Revenues USD 2.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 50.00M 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.92 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 205.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.97 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 7.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 904,734 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 7.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 437.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 15.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.98 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 437.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 15.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 3.98 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.85 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.47 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.22 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap ShortTermBorrowings Short-term Debt USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 559,167 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 814.54M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 712.89M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 2.74M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 262,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap SubleaseIncome Sublease Income USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap TradingSecuritiesDebtAmortizedCost Debt Securities, Trading, Amortized Cost USD 553.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap UnrealizedGainLossOnPriceRiskFairValueHedgingInstruments Unrealized Gain (Loss) on Price Risk Fair Value Hedging Instruments USD 33.60M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349168
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 51.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 51.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458388

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →